4.5 Article

The Effects of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy: An Open Label Quasi-Randomized Controlled Pilot Study

期刊

出版社

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.ctim.2020.102587

关键词

Aromatherapy; Chemotherapy; nursing; Nausea-Vomiting; Peppermint

资金

  1. Unit of Scientific Research Projects of Erciyes University [TDK-2017-7305]

向作者/读者索取更多资源

The study evaluated the effects of peppermint oil on reducing nausea, vomiting, and the severity of nausea in cancer patients undergoing chemotherapy. The results showed that peppermint oil significantly decreased the frequency and severity of these symptoms, particularly in patients receiving specific chemotherapy treatments.
Objectives: The current study evaluated the effects of peppermint oil on the frequency of nausea, vomiting, retching, and the severity of nausea in cancer patients undergoing chemotherapy. Design: A quasi-randomized controlled study. Setting: Patients were recruited from the ambulatory chemotherapy unit of a public hospital located (Batman, Turkey) between September 2017 and September 2018. Interventions: The participants in the intervention group applied one drop the aromatic mixture on the spot between their upper lip and their nose, three times a day for the five days following chemotherapy administration, in addition to the routine antiemetic treatment. Participants in the control group underwent only the routine antiemetic treatment. Main outcome measures VAS-the severity of nausea and the Index of Nausea, Vomiting, and Retching. Results: The VAS nausea score was significantly lower after peppermint oil applying in the patients receiving Folfirinox (treatment effect (mean dif.): 4.00 +/- 2.28; P<0.001), Paclitaxel-Trastuzumab (treatment effect (mean dif.): 1.70 +/- 0.90; P=0.014), Carboplatin-Paclitaxel (treatment effect (mean dif.): 3.71 +/- 1.41; P<0.001), and Cyclophosphamide-Adriamycin (treatment effect (mean dif.): 1.41 +/- 0.73; P=0.005) excluding cisplatin scedule (treatment effect (mean dif.): 0.56 +/- 2,18; P=0.642). We detected a statistical significant difference in the change in frequency of nausea, vomiting, retching in the other all schedules excluding cisplatin schedule (P<0.05). Conclusions: The peppermint oil was significantly reduced the frequency of nausea, vomiting, retching and the severity of nausea in cancer patients undergoing chemotherapy. Therefore, usage of peppermint oil together with antiemetics after chemotherapy with moderate and low emetic risk may be recommended to cope with CINV.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据